Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma

Published:2012-11-26 Issue:7 Volume:54 Page:1396-1404
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Xu Yuanlin¹,Wang Huaqing¹,Zhou Shiyong¹,Yu Man²,Wang Xianhuo¹,Fu Kai³,Qian Zhengzi¹,Zhang Huilai¹,Qiu Lihua¹,Liu Xianming¹,Wang Ping¹

Affiliation:

1. Department of Lymphoma, Tianjin Medical University Cancer Hospital, Sino-US Center for Lymphoma and Leukemia, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

2. Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Toronto, Canada

3. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.743657

Reference47 articles.

1. New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

2. Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

3. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

4. Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma;ESMO Open;2024-02

2. Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis;Scientific Reports;2024-01-03

3. Clinical features and prognosis of double primary malignant neoplasms in patients with non-hodgkin lymphoma;Discover Oncology;2023-05-03

4. Research Progress of Multiple Primary Malignancies Associated With Esophageal Cancer;Cancer Control;2023-04

5. Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors;Annals of Hematology;2023-01-09